Hauck & Aufhaeuser Reiterates “€55.00” Price Target for Gerresheimer (GXI)

Hauck & Aufhaeuser set a €55.00 ($67.90) price target on Gerresheimer (ETR:GXI) in a research note published on Thursday, January 18th. The firm currently has a sell rating on the stock.

A number of other equities research analysts also recently weighed in on the company. JPMorgan Chase & Co. set a €87.70 ($108.27) price target on Gerresheimer and gave the company a buy rating in a research report on Thursday, January 4th. Berenberg Bank set a €75.00 ($92.59) price objective on Gerresheimer and gave the stock a buy rating in a report on Friday, December 8th. Deutsche Bank set a €64.00 ($79.01) price objective on Gerresheimer and gave the stock a neutral rating in a report on Friday, December 1st. Kepler Capital Markets set a €65.00 ($80.25) price objective on Gerresheimer and gave the stock a sell rating in a report on Friday, November 3rd. Finally, Commerzbank set a €77.00 ($95.06) price objective on Gerresheimer and gave the stock a buy rating in a report on Monday, October 23rd. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company’s stock. Gerresheimer presently has an average rating of Hold and a consensus target price of €71.61 ($88.41).

Shares of Gerresheimer (ETR GXI) traded down €1.35 ($1.67) during mid-day trading on Thursday, hitting €64.40 ($79.51). The company had a trading volume of 139,645 shares, compared to its average volume of 116,507. Gerresheimer has a one year low of €59.97 ($74.04) and a one year high of €78.25 ($96.60). The stock has a market capitalization of $2,020.00 and a P/E ratio of 45.67.

ILLEGAL ACTIVITY NOTICE: “Hauck & Aufhaeuser Reiterates “€55.00” Price Target for Gerresheimer (GXI)” was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://stocknewstimes.com/2018/02/11/gerresheimer-gxi-given-a-55-00-price-target-at-hauck-aufhaeuser.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply